vs
Side-by-side financial comparison of FTAI Infrastructure Inc. (FIP) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
FTAI Infrastructure Inc. is the larger business by last-quarter revenue ($143.5M vs $123.8M, roughly 1.2× NATURES SUNSHINE PRODUCTS INC). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -68.1%, a 71.4% gap on every dollar of revenue. On growth, FTAI Infrastructure Inc. posted the faster year-over-year revenue change (77.7% vs 4.7%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $-68.6M). Over the past eight quarters, FTAI Infrastructure Inc.'s revenue compounded faster (31.9% CAGR vs 5.6%).
FTAI Infrastructure Inc. owns, operates and invests in high-quality critical infrastructure assets across core sectors including transportation logistics, midstream energy, and power generation. It primarily serves North American markets, focusing on assets with stable long-term cash flows, contracted revenue streams, and strong market positions to deliver sustainable returns for stakeholders.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
FIP vs NATR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $143.5M | $123.8M |
| Net Profit | $-97.7M | $4.1M |
| Gross Margin | — | 72.5% |
| Operating Margin | -45.7% | 4.3% |
| Net Margin | -68.1% | 3.3% |
| Revenue YoY | 77.7% | 4.7% |
| Net Profit YoY | 21.6% | 1379.4% |
| EPS (diluted) | $-1.04 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $143.5M | $123.8M | ||
| Q3 25 | $140.6M | $128.3M | ||
| Q2 25 | $122.3M | $114.8M | ||
| Q1 25 | $96.2M | $113.2M | ||
| Q4 24 | $80.8M | $118.2M | ||
| Q3 24 | $83.3M | $114.6M | ||
| Q2 24 | $84.9M | $110.6M | ||
| Q1 24 | $82.5M | $111.0M |
| Q4 25 | $-97.7M | $4.1M | ||
| Q3 25 | $-104.5M | $5.3M | ||
| Q2 25 | $-70.0M | $5.3M | ||
| Q1 25 | $120.2M | $4.7M | ||
| Q4 24 | $-124.7M | $-321.0K | ||
| Q3 24 | $-43.0M | $4.3M | ||
| Q2 24 | $-48.1M | $1.3M | ||
| Q1 24 | $-50.3M | $2.3M |
| Q4 25 | — | 72.5% | ||
| Q3 25 | — | 73.3% | ||
| Q2 25 | — | 71.7% | ||
| Q1 25 | — | 72.1% | ||
| Q4 24 | — | 72.0% | ||
| Q3 24 | — | 71.3% | ||
| Q2 24 | — | 71.4% | ||
| Q1 24 | — | 71.2% |
| Q4 25 | -45.7% | 4.3% | ||
| Q3 25 | -70.8% | 7.0% | ||
| Q2 25 | -56.4% | 3.7% | ||
| Q1 25 | 81.8% | 5.4% | ||
| Q4 24 | -152.7% | 3.8% | ||
| Q3 24 | -51.7% | 4.6% | ||
| Q2 24 | -56.4% | 5.1% | ||
| Q1 24 | -58.8% | 4.2% |
| Q4 25 | -68.1% | 3.3% | ||
| Q3 25 | -74.4% | 4.2% | ||
| Q2 25 | -57.2% | 4.6% | ||
| Q1 25 | 125.0% | 4.2% | ||
| Q4 24 | -154.4% | -0.3% | ||
| Q3 24 | -51.6% | 3.8% | ||
| Q2 24 | -56.7% | 1.2% | ||
| Q1 24 | -60.9% | 2.1% |
| Q4 25 | $-1.04 | $0.23 | ||
| Q3 25 | $-1.38 | $0.30 | ||
| Q2 25 | $-0.73 | $0.28 | ||
| Q1 25 | $0.89 | $0.25 | ||
| Q4 24 | $-1.21 | $-0.02 | ||
| Q3 24 | $-0.45 | $0.23 | ||
| Q2 24 | $-0.52 | $0.07 | ||
| Q1 24 | $-0.54 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $57.4M | $93.9M |
| Total DebtLower is stronger | $3.8B | — |
| Stockholders' EquityBook value | $21.3M | $161.6M |
| Total Assets | $5.7B | $261.1M |
| Debt / EquityLower = less leverage | 176.99× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.4M | $93.9M | ||
| Q3 25 | $34.7M | $95.6M | ||
| Q2 25 | $33.6M | $81.3M | ||
| Q1 25 | $26.3M | $86.5M | ||
| Q4 24 | $27.8M | $84.7M | ||
| Q3 24 | $20.3M | $78.7M | ||
| Q2 24 | $33.1M | $68.7M | ||
| Q1 24 | $23.0M | $77.8M |
| Q4 25 | $3.8B | — | ||
| Q3 25 | $3.7B | — | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $2.8B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.3B | $2.1M |
| Q4 25 | $21.3M | $161.6M | ||
| Q3 25 | $181.1M | $166.7M | ||
| Q2 25 | $375.5M | $163.7M | ||
| Q1 25 | $476.2M | $167.1M | ||
| Q4 24 | $202.7M | $161.0M | ||
| Q3 24 | $370.8M | $162.6M | ||
| Q2 24 | $394.8M | $156.4M | ||
| Q1 24 | $402.5M | $159.7M |
| Q4 25 | $5.7B | $261.1M | ||
| Q3 25 | $5.5B | $264.8M | ||
| Q2 25 | $4.4B | $254.9M | ||
| Q1 25 | $4.1B | $252.7M | ||
| Q4 24 | $2.4B | $240.9M | ||
| Q3 24 | $2.4B | $245.3M | ||
| Q2 24 | $2.5B | $235.8M | ||
| Q1 24 | $2.3B | $247.3M |
| Q4 25 | 176.99× | — | ||
| Q3 25 | 20.59× | — | ||
| Q2 25 | 8.21× | — | ||
| Q1 25 | 5.79× | — | ||
| Q4 24 | 7.84× | — | ||
| Q3 24 | 4.14× | — | ||
| Q2 24 | 3.94× | — | ||
| Q1 24 | 3.34× | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.8M | $9.9M |
| Free Cash FlowOCF − Capex | $-68.6M | $7.6M |
| FCF MarginFCF / Revenue | -47.8% | 6.1% |
| Capex IntensityCapex / Revenue | 45.9% | 1.9% |
| Cash ConversionOCF / Net Profit | — | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | $-398.5M | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.8M | $9.9M | ||
| Q3 25 | $-24.4M | $18.5M | ||
| Q2 25 | $-5.2M | $4.3M | ||
| Q1 25 | $-85.7M | $2.6M | ||
| Q4 24 | $-8.1M | $12.2M | ||
| Q3 24 | $14.2M | $9.6M | ||
| Q2 24 | $-17.6M | $1.3M | ||
| Q1 24 | $-3.9M | $2.2M |
| Q4 25 | $-68.6M | $7.6M | ||
| Q3 25 | $-90.7M | $16.8M | ||
| Q2 25 | $-87.5M | $3.0M | ||
| Q1 25 | $-151.7M | $1.5M | ||
| Q4 24 | $-34.3M | $10.0M | ||
| Q3 24 | $-11.7M | $7.9M | ||
| Q2 24 | $-32.1M | $-2.0M | ||
| Q1 24 | $-16.7M | $-1.5M |
| Q4 25 | -47.8% | 6.1% | ||
| Q3 25 | -64.5% | 13.1% | ||
| Q2 25 | -71.6% | 2.6% | ||
| Q1 25 | -157.7% | 1.3% | ||
| Q4 24 | -42.4% | 8.5% | ||
| Q3 24 | -14.0% | 6.9% | ||
| Q2 24 | -37.9% | -1.9% | ||
| Q1 24 | -20.3% | -1.4% |
| Q4 25 | 45.9% | 1.9% | ||
| Q3 25 | 47.2% | 1.3% | ||
| Q2 25 | 67.3% | 1.2% | ||
| Q1 25 | 68.6% | 1.0% | ||
| Q4 24 | 32.5% | 1.9% | ||
| Q3 24 | 31.1% | 1.5% | ||
| Q2 24 | 17.2% | 3.0% | ||
| Q1 24 | 15.6% | 3.3% |
| Q4 25 | — | 2.41× | ||
| Q3 25 | — | 3.46× | ||
| Q2 25 | — | 0.81× | ||
| Q1 25 | -0.71× | 0.55× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.21× | ||
| Q2 24 | — | 0.97× | ||
| Q1 24 | — | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FIP
| Power Revenues | $45.9M | 32% |
| Rail Revenue | $44.6M | 31% |
| Service Other | $22.8M | 16% |
| Gas Revenues | $15.3M | 11% |
| Roadside Services Revenues | $11.5M | 8% |
| Rapauno | $1.2M | 1% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
